$NVO.d
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (co...
$4,992.89
$43.10
13
$3,385.32
Novo-Nordisk A/S Metrics
Metric
Show % of Total
Market Cap by Network
Key Facts
Type
Fees
Fees
Market Data
Active Addresses
Transfer Count
Transfer Volume
Tokens
Primary Market
Investment
Fees
Fees
Service Providers
Custodian
Legal Identifier
Legal & Regulatory
U.S. Securities Act Reg. S Exemption
Segregation
Remote
Insurance
Fees
Fees
Fees
Fees
Fees
Holders
View detailed token
holder breakdowns
Sign up for a free account to get access to breakdowns of which investor addresses hold an RWA across blockchain networks.
RWA.xyzAll Rights Reserved